Literature DB >> 20118441

Association between joint hypermobility syndrome and panic disorder: a case-control study.

Javier García Campayo1, Elena Asso, Marta Alda, Eva Maria Andres, Natalia Sobradiel.   

Abstract

BACKGROUND: A significant association between joint hypermobility syndrome (JHS) and panic disorder was observed in a sample of rheumatology outpatients.
OBJECTIVE: The aim of this study was to assess whether JHS is more frequent in panic-disorder than in control subjects.
METHOD: The authors conducted a case-control study comparing 55 untreated patients with panic disorder and three matched-control groups: psychiatric patients, fibromyalgia patients, and healthy persons.
RESULTS: JHS was more frequent among panic-disorder than among psychiatric patients, the healthy group, or the fibromyalgia group. In the panic-disorder group, there was a significant correlation between severity of JHS and anxiety.
CONCLUSION: The strong association between JHS and panic disorder points to a genetic association. There is also a possibility that JHS and mitral valve prolapse, another condition frequently associated with panic disorder, share a common pathophysiological mechanism.

Entities:  

Mesh:

Year:  2010        PMID: 20118441     DOI: 10.1176/appi.psy.51.1.55

Source DB:  PubMed          Journal:  Psychosomatics        ISSN: 0033-3182            Impact factor:   2.386


  10 in total

Review 1.  Joint hypermobility and anxiety: the state of the art.

Authors:  Javier Garcia-Campayo; Elena Asso; Marta Alda
Journal:  Curr Psychiatry Rep       Date:  2011-02       Impact factor: 5.285

2.  Pain and gastrointestinal dysfunction are significant associations with psychiatric disorders in patients with Ehlers-Danlos syndrome and hypermobility spectrum disorders: a retrospective study.

Authors:  S Wasim; J S Suddaby; M Parikh; S Leylachian; B Ho; A Guerin; J So
Journal:  Rheumatol Int       Date:  2019-03-28       Impact factor: 2.631

3.  The risk factors and the impact of hernia development on technique survival in peritoneal dialysis patients: a population-based cohort study.

Authors:  Shang-Feng Yang; Chia-Jen Liu; Wu-Chang Yang; Chao-Fu Chang; Chih-Yu Yang; Szu-Yuan Li; Chih-Ching Lin
Journal:  Perit Dial Int       Date:  2014-03-01       Impact factor: 1.756

4.  Unexpected association between joint hypermobility syndrome/Ehlers-Danlos syndrome hypermobility type and obsessive-compulsive personality disorder.

Authors:  Massimo Pasquini; Claudia Celletti; Isabella Berardelli; Valentina Roselli; Simona Mastroeni; Marco Castori; Massimo Biondi; Filippo Camerota
Journal:  Rheumatol Int       Date:  2013-11-23       Impact factor: 2.631

5.  Clinical management of benign joint hypermobility syndrome: a case series.

Authors:  Patricia Adele Boudreau; Igor Steiman; Silvano Mior
Journal:  J Can Chiropr Assoc       Date:  2020-04

6.  Brain structure and joint hypermobility: relevance to the expression of psychiatric symptoms.

Authors:  Jessica A Eccles; Felix D C Beacher; Marcus A Gray; Catherine L Jones; Ludovico Minati; Neil A Harrison; Hugo D Critchley
Journal:  Br J Psychiatry       Date:  2012-04-26       Impact factor: 9.319

Review 7.  Neurovisceral phenotypes in the expression of psychiatric symptoms.

Authors:  Jessica A Eccles; Andrew P Owens; Christopher J Mathias; Satoshi Umeda; Hugo D Critchley
Journal:  Front Neurosci       Date:  2015-02-10       Impact factor: 4.677

8.  Structural brain abnormalities in postural tachycardia syndrome: A VBM-DARTEL study.

Authors:  Satoshi Umeda; Neil A Harrison; Marcus A Gray; Christopher J Mathias; Hugo D Critchley
Journal:  Front Neurosci       Date:  2015-03-17       Impact factor: 4.677

Review 9.  Ehlers-Danlos Syndrome in the Field of Psychiatry: A Review.

Authors:  Hiroki Ishiguro; Hideaki Yagasaki; Yasue Horiuchi
Journal:  Front Psychiatry       Date:  2022-01-11       Impact factor: 4.157

10.  Ehlers-danlos syndrome, hypermobility type: an underdiagnosed hereditary connective tissue disorder with mucocutaneous, articular, and systemic manifestations.

Authors:  Marco Castori
Journal:  ISRN Dermatol       Date:  2012-11-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.